Bolt Biotherapeutics BOLT
NASDAQ BOLT
$3.59 +0.13 (+3.75%)
As of: Sep 29, 2026 · 2:39 PM EDT

Bolt Biotherapeutics (BOLT) Restructuring Costs (2024 - 2025)

Updated

Bolt Biotherapeutics (BOLT) posted Restructuring Costs of $1.48 million for Q4 2025, compared with -$222,000 a year earlier.

Analysis

Bolt Biotherapeutics (BOLT) Restructuring Costs (2024 - 2025) Analysis & Trends

  • In prior years, Bolt Biotherapeutics' Restructuring Costs was $3.34 million in FY2024.
  • The Q4 2025 figure stands as the highest quarterly Restructuring Costs since Q2 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Bolt Biotherapeutics 6.88 Mn 6.88 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 1.48 Mn
Dec 31, 2024 -222,000.00
Jun 30, 2024 3.57 Mn
API Access

Bolt Biotherapeutics Restructuring Costs API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=restructuring-costs&ticker=BOLT&period=max&api_key=YOUR_API_KEY